Analysed ELITE PHARMACEUTICALS INC (ELTP:OTCMKTS) News Sources
The Zacks Analyst Blog Highlights GE Aerospace, Shell, McKesson, Elite Pharmaceuticals and Geospace Technologies
18-03-2026
yahoo.com
Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets
02-04-2026
yahoo.com
Elite Pharmaceuticals Announces Filing of Abbreviated New Drug Application with the U.S. Food and Drug Administration for Generic Anticoagulant Product
01-06-2026
yahoo.com
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
15-06-2026
yahoo.com
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2026 Financial Results on June 30, 2026
23-06-2026
yahoo.com
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2026 and Provides Conference Call Information
29-06-2026
yahoo.com
Elite Pharmaceuticals Inc (ELTP) Q4 2026 Earnings Call Highlights: Record Revenue Growth and ...
01-07-2026
yahoo.com
What is the current price of ELITE PHARMACEUTICALS INC (ELTP:OTCMKTS)?
The current price of ELITE PHARMACEUTICALS INC (ELTP:OTCMKTS) is $0.399.
ELITE PHARMACEUTICALS INC (ELTP:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ELITE PHARMACEUTICALS INC (ELTP:OTCMKTS) since the previous trading day is $0.0241.
ELITE PHARMACEUTICALS INC (ELTP:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ELITE PHARMACEUTICALS INC (ELTP:OTCMKTS) since the previous trading day is 6.4284%.
What is the most recent average sentiment score for ELITE PHARMACEUTICALS INC (ELTP:OTCMKTS)?
The most recent average sentiment score for ELITE PHARMACEUTICALS INC (ELTP:OTCMKTS) is 83 out of 100.
What is the most recent average sentiment for ELITE PHARMACEUTICALS INC (ELTP:OTCMKTS)?
The most recent sentiment for ELITE PHARMACEUTICALS INC (ELTP:OTCMKTS) is .
SEC-8K** Filing Available For ELITE PHARMACEUTICALS INC (ELTP:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.